These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6966947)

  • 21. Reduction of granulocyte-macrophage progenitor cells (CFU-C) and fibroblastoid colony-forming units (CFU-F) by leukemic cells in human and murine leukemia.
    Nara N; Jinnai I; Imai Y; Bessho M; Hirashima K
    Acta Haematol; 1984; 72(3):171-80. PubMed ID: 6438981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Friend virus-infected long-term bone marrow cultures produce colony stimulating factor dependent and independent granulocyte-macrophage progenitor cells for over four years in vitro.
    Greenberger JS; Daugherty C; Sakakeeny MA; Braun J; Pierce JH; Eckner RJ; FitzGerald TJ
    Leuk Res; 1987; 11(1):51-61. PubMed ID: 3492638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the production of leukemia associated inhibitor (LAI) and its interaction with granulocyte-macrophage colony-forming cells.
    Olofsson T; Sallerfors B
    Exp Hematol; 1987 Dec; 15(11):1163-7. PubMed ID: 3500070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purified murine granulocyte/macrophage progenitor cells express a high-affinity receptor for recombinant murine granulocyte/macrophage colony-stimulating factor.
    Williams DE; Bicknell DC; Park LS; Straneva JE; Cooper S; Broxmeyer HE
    Proc Natl Acad Sci U S A; 1988 Jan; 85(2):487-91. PubMed ID: 2829188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of normal erythropoiesis in vitro by macrophages from erythroleukemic mice.
    Johnson CS; Marcelletti J; Furmanski P
    J Natl Cancer Inst; 1984 Feb; 72(2):491-6. PubMed ID: 6582332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of leukemia cell-derived inhibitory activity (LIA) in conditioned media from human myeloid leukemic cell line ML-2.
    Cukrová V; Hrkal Z; Koprivová H; Neuwirt J
    Blut; 1986 Jan; 52(1):51-8. PubMed ID: 3484646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proliferation of hemopoietic stem cells and development of potentially leukemic cells in vitro.
    Dexter TM; Laijtha LG
    Bibl Haematol; 1975 Oct; (43):1-5. PubMed ID: 1085618
    [No Abstract]   [Full Text] [Related]  

  • 28. The Friend murine erythroleukemia cell, a model system for studying the association between bone marrow toxicity induced by 3'-azido-3'-dideoxythymidine and dideoxynucleoside inhibition of mtDNA replication.
    Hobbs GA; Keilbaugh SA; Simpson MV
    Biochem Pharmacol; 1992 Apr; 43(7):1397-1400. PubMed ID: 1567464
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production.
    Doig D; Chesebro B
    J Exp Med; 1979 Jul; 150(1):10-9. PubMed ID: 286744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H-2D (Rfv-1) gene influence on recovery from Friend virus leukemia is mediated by nonleukemic cells of the spleen and bone marrow.
    Britt WJ; Chesebro B
    J Exp Med; 1980 Dec; 152(6):1795-804. PubMed ID: 6935387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocytic stem cells in Friend leukemia.
    Golde DW; Faille A; Sullivan A; Friend C
    Cancer Res; 1976 Jan; 36(1):115-9. PubMed ID: 1082368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferential inhibitory effect of soluble factor(s) in human bone marrow stromal cells on proliferation of K562 leukemia cells versus normal myeloid progenitor cells.
    Aoyagi A; Aoyagi M; Waga K; Enokihara H; Furusawa S
    Int J Hematol; 1996 Apr; 63(3):205-13. PubMed ID: 8936334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of differentiation of Friend erythroleukemia cells with L histidinol.
    Kundahl E; Flickinger RA
    Life Sci; 1981 Sep; 29(12):1203-5. PubMed ID: 6946270
    [No Abstract]   [Full Text] [Related]  

  • 34. Interleukin-4 induces a substance in bone marrow stromal cells that reversibly inhibits factor-dependent and factor-independent cell proliferation.
    Peschel C; Green I; Paul WE
    Blood; 1989 Apr; 73(5):1130-41. PubMed ID: 2495033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro.
    Sing GK; Keller JR; Ellingsworth LR; Ruscetti FW
    Blood; 1988 Nov; 72(5):1504-11. PubMed ID: 2460153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatin remodeling gene SMARCA5 is dysregulated in primitive hematopoietic cells of acute leukemia.
    Stopka T; Zakova D; Fuchs O; Kubrova O; Blafkova J; Jelinek J; Necas E; Zivny J
    Leukemia; 2000 Jul; 14(7):1247-52. PubMed ID: 10914549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A stimulator of mouse stem cell proliferation produced by human regenerating bone marrow.
    Oishi H; Katsuno M; Umemura T; Nishimura J; Motomura S; Ibayashi H
    Leuk Res; 1987; 11(8):699-704. PubMed ID: 3498096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiopathology of human and virus-induced murine leukemias.
    Jasmin C; Joffe FS; Klein B; Kerdiles-LeBousse C
    Cancer Res; 1976 Feb; 36(2 pt 2):603-7. PubMed ID: 175921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of interleukin-4 on the growth of granulocyte-macrophage progenitor cells stimulated by hematopoietic growth factors.
    Sato T; Misago M; Tsukada J; Kikuchi M; Oda S; Chiba S; Eto S
    J UOEH; 1990 Jun; 12(2):163-74. PubMed ID: 1697091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphokine-activated killer cell plus recombinant interleukin-2 therapy of erythroleukemia in mice.
    Johnson CS; Thurlow SM; Furmanski P
    Leukemia; 1989 Feb; 3(2):91-6. PubMed ID: 2783472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.